Evidence
VOINOSIS validates its technological excellence through awards, clinical research,
scientific publications, and a robust patent portfolio.
Held at ICASSP 2023
The MADRess Challenge No.1
Winner of the Multilingual Alzheimer’s Detection Category
2023 Global Startup World Cup
Joint 2nd Place Worldwide
Recognized as one of the world’s leading startups
Clinical Research & Publications
Peer-reviewed clinical studies and international scientific publications validating
the reliability and performance of VOINOSIS voice AI
50+ Peer-reviewed
publications
Research achievements validated through rigorous international peer review
20+ Clinical Research
Collaborations
Extensive joint research conducted with leading institutions worldwide
Publications in
SCI/SCIE-Indexed Journals
Demonstrating global research excellence through publications in top-tier journals
Patent Portfolio
VOINOSIS has filed international patent applications for its AI diagnostic technology based
on voice analysis, securing its intellectual property rights.
PCT/KR2023/016129 (2023-10-18)
AI-Based Hearing Loss Diagnosis Method Using Voice Data
PCT/KR2023/016134 (2023-10-18)
AI-Based Alzheimer’s Diagnosis and Cognitive Impairment Severity Prediction Method
PCT/KR2023/016137 (2023-10-18)
AI-Based Alzheimer’s Detection Method Using Prosodic Features in Speech
PCT/KR2023/016138 (2023-10-18)
Voice Data Collection Method for Constructing Brain Health Diagnostic Indicators
PCT/KR2023/016140 (2023-10-18)
AI-Based Screening System for Hearing Loss, Cognitive Impairment, and Dementia Using Voice Data